This disclosure relates to a class of novel 6-substituted-5-phenyitetrazolo[1,5-a][1,2,4]truaziki[1,5-c]otrunudubes and to pharmaceutical compositions containing such compounds. The compounds and compositions disclosed are useful as renal vasodilators, diuretics and/or anti-hypertensive agents for the treatment of hypertensive disorders in humans.
本公开涉及一类新型 6-取代-5-苯基
四唑并[1,5-a]
[1,2,4]三嗪并[1,5-c]奥曲
呋喃和含有此类化合物的药物组合物。所公开的化合物和组合物可用作治疗人类高血压疾病的肾血管扩张剂、利尿剂和/或抗高血压剂。